Demo Sign up Log In

Aclaris Therapeutics Inc (ACRS)

Cash Conversion Ratio

0.93×

Quarterly · Period ending: Jun 30, 2026

ACRS Cash Conversion Ratio

Latest reported0.93×period endingJun 30, 2026

Latest reported0.93×period endingJun 30, 2026

ACRS Quarterly Cash Conversion Ratio (0.77× → 0.93×)

Latest values, visible window

High-resolution chart · PNG

ACRS cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aclaris Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	0.9262×
Mar 31, 2026	0.9155×
Dec 31, 2025	0.6646×
Sep 30, 2025	0.7496×
Jun 30, 2025	0.649×
Mar 31, 2025	0.9236×
Dec 31, 2024	0.4635×
Sep 30, 2024	-2.9001×
Jun 30, 2024	1.1203×
Mar 31, 2024	1.2366×
Dec 31, 2023	4.8303×
Sep 30, 2023	0.8421×
Jun 30, 2023	0.7063×
Mar 31, 2023	0.9555×
Dec 31, 2022	0.6955×
Sep 30, 2022	0.3993×
Jun 30, 2022	0.9669×
Mar 31, 2022	1.1248×
Dec 31, 2021	0.7575×
Sep 30, 2021	0.5042×
Jun 30, 2021	0.6758×
Mar 31, 2021	0.4254×
Dec 31, 2020	0.673×
Sep 30, 2020	1.1684×
Jun 30, 2020	0.9346×
Mar 31, 2020	0.4446×
Dec 31, 2019	1.1109×
Sep 30, 2019	0.4371×
Jun 30, 2019	0.4335×
Mar 31, 2019	0.8413×
Dec 31, 2018	0.7106×
Sep 30, 2018	0.9291×
Jun 30, 2018	0.7106×
Mar 31, 2018	0.7334×
Dec 31, 2017	0.8192×
Sep 30, 2017	0.7687×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.